Homestead Advisers Corp boosted its stake in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 0.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 942,589 shares of the biopharmaceutical company’s stock after acquiring an additional 1,600 shares during the quarter. Homestead Advisers Corp’s […]